Every recall we track for SUN PHARMACEUTICAL INDUSTRIES INC — 137 in all — plus the complaints and injury reports the public filed about them.
Sun Pharmaceutical recalls 200mg Carbamazepine tablets with black spots caused by burnt excipients during manufacturing. Rx-only medication distributed by Taro Pharmaceuticals USA. No remedy specified in official notice.
Sun Pharmaceutical recalls Perampanel CIII 6mg tablets due to label mix-up with 10mg tablets. Affected units contain incorrect labeling that may lead to incorrect dosing.
Sun Pharmaceutical recalls 180mg fexofenadine tablets due to failed impurities and degradation specifications. Affected lots expire by March 2027 or October 2026. Consumers should check NDC codes and lot numbers.
Sun Pharmaceutical is recalling Budesonide Inhalation Suspension due to black/brown particles found in some ampules. This may cause irritation or injury if inhaled. Consumers should check their product and contact the company for details.
SUN PHARMACEUTICAL INDUSTRIES INC recalls Xyvona 3mg tablets due to FDA denying marketing approval. This prescription drug was manufactured by Ohm Laboratories and distributed by Forte BioPharma.
SUN PHARMACEUTICAL INDUSTRIES INC recalls Xyv: 2mg tablets due to FDA denying marketing under proprietary name Xyvona. No remedy specified in official notice.
Sun Pharmaceutical recalls DOXOrubin Hydrochloride Liposome injections due to glass particles. This may cause serious injury if injected. Affected lots: HAG2581B, expires 05/31/2027.
Sun Pharmaceutical Industries recalls 0.05% Fluocinonide cream due to failed viscosity testing. This may affect product stability and safety. Consumers should contact the manufacturer for details.
Sun Pharmaceutical recalls 0.05% Fluocinonide cream due to failed viscosity tests. This may affect stability and safety. Check your product details to see if it's affected.
Sun Pharmaceutical Industries recalls 0.05% Fluocinonide cream due to failed viscosity tests. This may affect stability and product performance. Contact for details.
Sun Pharmaceutical Industries recalls Diclofenac Sodium Topical Gel 3% due to failed viscosity specifications. This may affect product stability and effectiveness.
Sun Pharmaceutical recalls 0.01% Fluocinolone Acetonide Solution Topical Solution bottles due to impurity D. This may affect safety for patients using prescription steroid creams.
SUN PHARMACEUTICAL recalls Clindamycin Phosphate topical solution due to impurities and degradation. This medication is prescription-only and may pose risks if used improperly.
Sun Pharmaceutical recalls 30mg Lisdexamfetamine Dimesylate capsules due to failed dissolution test at 12 months. This may affect drug effectiveness. Check NDC 57664-048-88 and lot numbers for affected products.
Sun Pharmaceutical recalls 40mg Lisdexamfetamine Dimesylate capsules due to failed dissolution test at 12 months. This may affect medication effectiveness. Check NDC 57664-049-88 and lot numbers AD48709 or AD50894.
Sun Pharmaceutical recalls 10mg Lisdexamfetamine Dimesylate capsules due to failed dissolution test at 12 months. This may affect medication effectiveness. Check NDC 57664-046-88 and lot numbers.
Sun Pharmaceutical recalls 20mg Lisdexamfetamine Dimesylate capsules with failed dissolution tests. These prescription-only capsules may not release medication properly.
Sun Pharmaceutical recalls 70mg lisdexamfetamine capsules with failed dissolution tests. This may affect drug stability and safety. Check NDC 57664-052-88 for affected lots.
Sun Pharmaceutical recalls 50mg Lisdexamfetamine Dimesylate capsules due to failed dissolution tests at 12 months. This may affect medication reliability. Check NDC 57664-050-88 and lot numbers for affected products.
Sun Pharmaceutical recalls 60mg Lisdexamfetamine Dimesylate capsules with failed dissolution tests. This may affect medication stability. Contact for return instructions.
Sun Pharmaceutical recalls Mertiatide kits with failed dissolution specifications due to sulfate issues in Sodium Tartrate Dihydrate. This affects specific lots and NDC numbers. Contact for details.
Sun Pharmaceutical recalls 25mg spironolactone tablets with aluminum foreign substance. This could cause harm if ingested. Contact Sun Pharmaceutical for details.
Sun Pharmaceuticals recalls 60mg lisdexamfetamine capsules (NDC 57664-051-88) due to failed dissolution tests at 9 months. This may affect drug stability and safety.
Sun Pharmaceutical recalls 300mg gabapentin capsules (NDC 62756-138-04/05) due to cross contamination risk. Affected lots expire 2025. Consumers should contact Sun Pharmaceutical for details.
Sun Pharmaceutical recalls 500-count and 1000-count Gabapentin 400mg capsules due to cross contamination risk. Affected lots expire March 2025. Consumers should check NDC codes and lot numbers.
Sun Pharmaceutical recalls 100mg Morphine Sulfate Extended-Release Tablets (100-count) due to failed dissolution specifications. This may affect medication effectiveness. Check NDC 63304-452-01 and lot number AD16615.
Sun Pharmaceutical recalls Nitrofurantoin Capsules (100mg) due to failed dissolution specifications. This may affect medication effectiveness. Check NDC 57664-233-88 and lot numbers 231067, 231069.
Sun Pharmaceutical recalls Decitabine injection vials due to potential microbial contamination. This drug is for IV use only and requires a prescription. Affected units have specific NDC and expiration dates.
Sun Pharmaceutical recalls Xelpros (latanoprost) 0.005% ophthalmic emulsion due to particulate matter test failure. This may cause eye irritation or injury. Affected units have specific NDC and lot numbers.
Sun Pharmaceutical recalls 50mg Amphotericin B Liposome vials (NDC 62756-233-01) due to assay out of specification. This may affect drug effectiveness. Contact the manufacturer for details.
Sun Pharmaceutical recalls Febuxostat 40mg tablets (NDC 16714-059-01) due to microbial contamination in manufacturing equipment. Affected lots DNE0865A and DNE0866A expire June 2025. Consumers should not use these products.
Sun Pharmaceutical recalls Febuxostat 80mg tablets due to microbial contamination in manufacturing equipment. This recall affects RX-only products with NDC 16714-060-01, lot DNE0894A, expiring 07/31/2025. Consumers should check their bottles for the specific lot number.
Sun Pharmaceutical Industries recalls 180mg fexofenadine tablets due to microbial contamination in manufacturing equipment. Affected lots from India with specific NDC numbers and expiration dates. Consumers should check their product details and contact the manufacturer for guidance.
Sun Pharmaceutical recalls 6.25mg Zolpidem Extended-Release Tablets due to microbial contamination in manufacturing equipment. Affected lots may pose health risks if used.
Sun Pharmaceutical recalls Febuxostat 40mg tablets due to microbial contamination in manufacturing equipment. Affected lots expire June 2025 and August 2025. Consumers should check NDC 47335-721-83 and lot numbers.
Sun Pharmaceutical recalls Febuxostat 80mg tablets due to microbial contamination in manufacturing equipment. Affected lots expire June 2025 and July 2025. Consumers should check NDC 47335-722-83 and lot numbers.
Sun Pharmaceutical recalls 1000mg Niacin Extended-Release Tablets due to microbial contamination in manufacturing equipment. Affected lots may pose health risks if used.
Sun Pharmaceutical recalls 500mg niacin extended-release tablets due to microbial contamination in manufacturing equipment. Affected lots expire June 2025. Consumers should not use these products.
Sun Pharmaceutical recalls 120mg Lurasidone Hydrochloride tablets due to microbial contamination in manufacturing equipment. Affected lots expire 11/30/2024 and 12/31/2024. Consumers should contact the manufacturer for details.
Sun Pharmaceutical recalls Cinacalcet 60mg tablets due to microbial contamination in manufacturing equipment. This recall affects specific lots and requires immediate action to prevent potential health risks.
Sun Pharmaceutical recalls Mesalamine Delayed-Release Tablets due to microbial contamination in manufacturing equipment. Affected lots expire by March 2025. Consumers should check NDC 63304-175-13 and lot numbers for affected products.
Sun Pharmaceutical recalls 12.5mg Zolpidem Extended-Release Tablets due to microbial contamination in manufacturing equipment. Affected lots may pose health risks if used.
Sun Pharmaceutical recalls 200mg bupropion extended-release tablets due to failed dissolution specifications. This may affect product effectiveness. Consumers should contact Sun for details.
Sun Pharmaceutical recalls 25 mcg Liothyronine Sodium Tablets due to failed impurities and degradation specifications. Rx-only bottles with NDC 62756-590-88 may pose safety risks.
Sun Pharma recalls Cequa (cyclosporine ophthalmic solution) 0.09% due to subpotent results. This may affect medication effectiveness. Check NDC 47335-506-96, lots 10026/10027, expiring 09/2023.
Sun Pharmaceutical recalls 500 mcg Dofet: 60-count bottles due to content uniformity testing failures. This may affect medication accuracy. Contact for return instructions.
Sun Pharmaceutical recalls 20mg methylphenidate tablets with metal embedded in some tablets. This could cause injury if swallowed. Consumers should contact the company for details.
Sun Pharmaceutical recalls Loteprednol Etabonate Ophthalmic Suspension due to out of specification unit dose content. This may affect eye safety. Contact for details.
Sun Pharmaceutical recalls Amphotericin B Liposome injections due to subpotent drug levels. This may reduce effectiveness for serious fungal infections. Patients with prescribed treatment should contact their doctor.
Sun Pharmaceutical recalls 150mg buPROPrion Hydrochloride Extended-Release Tablets (NDC 47335-737-86) that failed dissolution testing during stability checks. This could affect medication effectiveness.
Sun Pharmaceutical recalls norepinephrine injection vials with impurity levels above safety limits. This may cause adverse reactions. Stop using and contact for details.
Sun Pharmaceutical recalls 500 mcg Dofetilide capsules due to failed content uniformity. This may affect medication accuracy. Contact for return instructions.
Sun Pharmaceutical recalls 360mg Diltiazem Hydrochloride Extended-Release Capsules due to failed impurity and dissolution testing. Rx-only bottles with specific lot numbers and expiration dates are affected.
